Synutra Provides Update on Infant Formula Allegations Media Coverage

August 12, 2010

QINGDAO, China and ROCKVILLE, Md., Aug. 12 /PRNewswire-Asia/ — Synutra
International, Inc. (Nasdaq: SYUT), a leading infant formula company in China
and a producer, marketer and seller of nutritional products for infants,
children and adults, today provided an update on media coverage of infant
formula allegations by highlighting the following articles.

— Fonterra’s Official Announcement

Fonterra Cooperative Group Ltd., a supplier of milk powder to Synutra
International, announced on August 11, 2010 that it remains 100% confident in
the quality of its products. It stated that New Zealand’s strict legislative
controls prohibit the use of Hormonal Growth Promotants (HGPs) on milk
producing cows. For more details, please see http://tinyurl.com/2dng5la .

— Experts Find No Direct Links Between Premature Development and
Synutra’s Infant Formula

CBN reported today that a panel of experts, assembled by the Ministry of
Health on August 11, 2010 to investigate the premature development claims in
Hubei, found no evidence to link the three infant girls’ premature development
with Synutra’s infant formula. For more details, please see
http://www.yicai.com/news/2010/08/389899.html .

— Expert Believes Artificial Hormones were not Added to Cow Feed

The Jinghua Times reported that Shuhuai Wang, a researcher with China’s
Institute of Veterinary Drug Control, stated during an interview regarding
hormones that companies would not add artificial estrogen hormones to cow feed
as it will disrupt milk production. For more information, please see
http://news.sina.com.cn/h/2010-08-11/013520868785.shtml .

As additional material information becomes available, Synutra will
continue to provide updates on the situation.

About Synutra International, Inc.

Synutra International Inc. (Nasdaq: SYUT) is a leading infant formula
company in China. It principally produces, markets and sells its products
under the “Shengyuan” or “Synutra” name, together with other complementary
brands. It focuses on selling premium infant formula products, which are
supplemented by more affordable infant formulas targeting the mass market as
well as other nutritional products and ingredients. It sells its products
through an extensive nationwide sales and distribution network covering 30
provinces and provincial-level municipalities in China. As of June 30, 2010,
this network comprised over 560 independent distributors and over 1,000
independent sub-distributors who sell Synutra products in over 74,000 retail

Forward-looking Statements

This press release contains “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995 that are based
on our current expectations, assumptions, estimates and projections about
Synutra International Inc. and its industry. All statements other than
statements of historical fact in this release are forward-looking statements.
In some cases, these forward-looking statements can be identified by words or
phrases such as “anticipate,” “believe,” “continue,” “estimate,” “expect,”
“intend,” “is/are likely to,” “may,” “plan,” “should,” “will,” “aim,”
“potential,” “continue,” or other similar expressions. The forward-looking
statements included in this press release relate to, among others, Synutra’s
goals and strategies; its future business development, financial condition and
results of operations; the expected growth of the nutritional products and
infant formula markets in China; market acceptance of the Company’s products;
adverse effects associated with the melamine contamination incident; Synutra’s
expectations regarding demand for its products; Synutra’s ability to stay
abreast of market trends and technological advances; competition in the infant
formula industry in China; PRC governmental policies and regulations relating
to the nutritional products and infant formula industries, and general
economic and business conditions in China. These forward-looking statements
involve various risks and uncertainties. Although Synutra believes that the
expectations expressed in these forward-looking statements are reasonable,
these expectations may turn out to be incorrect. Synutra’s actual results
could be materially different from the expectations. Important risks and
factors that could cause actual results to be materially different from
expectations are generally set forth in the “Item 1. Business,” “Item 1A. Risk
Factors,” “Item 7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations,” and other sections in Synutra’s Form 10-K filed
with the Securities and Exchange Commission on June 9, 2010. The
forward-looking statements are made as of the date of this press release.
Synutra International Inc. undertakes no obligation to update any
forward-looking statements to reflect events or circumstances after the date
on which the statements are made or to reflect the occurrence of unanticipated

    For further information, please contact:

     Synutra International, Inc.
     Investor Relations Department
     Phone: +1-301-840-3881
     Email: ir@synutra.com

SOURCE Synutra International, Inc.

Source: newswire

comments powered by Disqus